FL-H.I.G.-CAPITAL
11.3.2024 09:42:29 CET | Business Wire | Press release
H.I.G. Capital (“H.I.G.“), a leading global alternative investment firm with $60 billion of capital under management, is pleased to announce that it has signed a definitive agreement to sell its German portfolio company ICG Group (the “company” or “ICG”) to SPIE Group, a European leader in multi-technical services in the areas of energy and communications, listed on the Paris stock exchange (Ticker: SPIE). ICG’s management will remain in place and continue to drive the company’s future development. The transaction is subject to clearance by antitrust authorities.
ICG Group was initially launched in 2021, with H.I.G.’s platform investment in Infratech, which builds complex FTTx networks on behalf of public and private German network operators. ICG subsequently acquired comcross, one of Germany’s leading service providers for mobile telecommunication infrastructure. The mobile communication segment was further developed through ICG’s bolt-on investments in telecommunication solutions providers Schwan and TripleA as well as telecommunication network planner DPE. Today, ICG has more than 700 employees in 16 locations throughout Germany, mainly, as well as in the Netherlands, and Croatia. The company has built more than 15,000 mobile communications sites, deployed more than 15,000 kilometers of fiber-optic lines, and connected more than 100,000 households to the fiber-optic network ("homes passed"). ICG’s revenue quadrupled during H.I.G.’s ownership.
Holger Kleingarn, Managing Director at H.I.G., commented, “We are very pleased to have assembled the ICG Group, uniquely offering customers a single point of contact for the entire value chain of digital infrastructure services. Our engagement in ICG underlines H.I.G.’s expertise in identifying strong platforms in key future industries and sustainably expanding them via organic growth and selected acquisitions. We have established ICG Group as the leading enabler of next-generation infrastructures and turnkey network solutions in Germany and beyond. We thank the management team of Vladimir Suznjevic and Gregor Klaßen for the highly trustful and successful partnership and wish them continued success for the next phase of ICG Group’s development.”
Vladimir Suznjevic, Managing Director of ICG Group and responsible for the mobile communication business, commented, "Technologies such as Industry 4.0, autonomous driving, and artificial intelligence require a significant expansion of digital infrastructure in Germany and Europe. In addition, while the 5G mobile communication standard is currently being rolled out, 6G is already in development. In order to best drive the European digitization, a technical integration of mobile communications and fiber-optic infrastructure is key. At ICG, with the support of H.I.G. and now SPIE, we are ideally positioned to continue meeting this requirement for the benefit of our trusted customers."
Gregor Klaßen, Managing Director of Infratech and responsible for its fiber-optic business, commented, "Germany will catch up to the industrialized countries in fiber optic roll-out over the next decade, resulting in an ongoing high demand for experienced and reliable service providers in the areas of fiber optic planning, civil engineering, and installation. We have trusted relationships with our public-sector and corporate clients, allowing us to implement large turnkey networks for them. We thank H.I.G. for the strong support over the past years. We are looking forward to continue ICG’s success story as part of SPIE Group."
About ICG Group
ICG Group, headquartered in Leonberg (Germany), combines the competencies of the leading communication infrastructure service providers: Infratech, comcross, Schwan, TripleA Networks, and DPE. The Group covers the entire value chain from planning and construction to installation and maintenance of infrastructures for fiber-optic, mobile communications, and electricity networks. All units of the Group are characterized by a strong position in their respective segments and long-standing customer relationships. The ICG Group has more than 700 employees in 16 locations throughout Germany, mainly, as well as in the Netherlands, and Croatia. For more information, please visit icg-gruppe.de.
About H.I.G. Capital
H.I.G. Capital is a leading global alternative investment firm with $60 billion of capital under management.* Based in Miami, and with offices in Atlanta, Boston, Chicago, Dallas, Los Angeles, New York, and San Francisco in the United States, as well as international affiliate offices in Hamburg, London, Luxembourg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro, São Paulo, and Dubai, H.I.G. specializes in providing both debt and equity capital to middle market companies, utilizing a flexible and operationally focused/value-added approach:
- H.I.G.’s equity funds invest in management buyouts, recapitalizations and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
- H.I.G.’s debt funds invest in senior, unitranche and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. also manages a publicly traded BDC, WhiteHorse Finance.
- H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.
- H.I.G. Infrastructure focuses on making value-add and core plus investments in the infrastructure sector.
Since its founding in 1993, H.I.G. has invested in and managed more than 400 companies worldwide. The Firm's current portfolio includes more than 100 companies with combined sales in excess of $53 billion. For more information, please refer to the H.I.G. website at hig.com.
*Based on total capital raised by H.I.G. Capital and its affiliates.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240308259866/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
